Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -232.05% is 84% below its 5-year average of -125.96%, around the middle of its 5-year range (-559.76%–-59.24%).
As of the fiscal period ended Tuesday, June 30, 2026. 16.84% above its 12-month average of -279.05%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -232.05%.
RETURN ON INVESTED CAPITAL (ROIC)
-232.05%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-279.05%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-124.64%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-125.96%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-85.14%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+16.84%
CURRENT VS 3Y AVG
-86.18%
CURRENT VS 5Y AVG
-84.23%
CURRENT VS 10Y AVG
-172.54%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.73%
median of 709 covered companies
CURRENT VS SECTOR MEDIAN
-587.98%
vs the sector median at left
KALA BIO, Inc.
Market Cap
$7.07M
Return on Invested Capital (ROIC)
-232.05%
TTM Avg
-279.05%
3Y Avg
-124.64%
5Y Avg
-125.96%
Market Cap
$7.08M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-383.35%
3Y Avg
-220.46%
5Y Avg
-246.83%
Market Cap
$7.07M
Return on Invested Capital (ROIC)
-102.91%
TTM Avg
-91.30%
3Y Avg
-374.81%
5Y Avg
-315.39%
Market Cap
$7.20M
Return on Invested Capital (ROIC)
-208.39%
TTM Avg
-54.78%
3Y Avg
-47.23%
5Y Avg
-47.23%
Market Cap
$7.31M
Return on Invested Capital (ROIC)
-995.44%
TTM Avg
-481.38%
3Y Avg
-268.85%
5Y Avg
-219.77%
Market Cap
$7.33M
Return on Invested Capital (ROIC)
-211.58%
TTM Avg
-206.45%
3Y Avg
-187.44%
5Y Avg
-143.49%
Market Cap
$7.37M
Return on Invested Capital (ROIC)
-92.94%
TTM Avg
-279.36%
3Y Avg
-244.50%
5Y Avg
-201.18%
Market Cap
$6.80M
Return on Invested Capital (ROIC)
-90.17%
TTM Avg
-79.44%
3Y Avg
-64.42%
5Y Avg
-71.54%
Market Cap
$6.74M
Return on Invested Capital (ROIC)
-57.11%
TTM Avg
-311.64%
3Y Avg
-524.77%
5Y Avg
-524.77%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| KALA BIO, Inc. (KALA) | $7.07M | -232.05% | -279.05% | -124.64% | -125.96% |
| NeuroSense Therapeutics Ltd. (NRSN)vs › | $7.08M | N/A | -383.35% | -220.46% | -246.83% |
| Mangoceuticals, Inc. (MGRX)vs › | $7.07M | -102.91% | -91.30% | -374.81% | -315.39% |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.20M | -208.39% | -54.78% | -47.23% | -47.23% |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.31M | -995.44% | -481.38% | -268.85% | -219.77% |
| Longeveron Inc. (LGVN)vs › | $7.33M | -211.58% | -206.45% | -187.44% | -143.49% |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.37M | -92.94% | -279.36% | -244.50% | -201.18% |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.80M | -90.17% | -79.44% | -64.42% | -71.54% |
| Aclarion, Inc. (ACON)vs › | $6.74M | -57.11% | -311.64% | -524.77% | -524.77% |
| Co-Diagnostics, Inc. (CODX)vs › | $6.69M | -219.15% | -109.13% | -72.14% | -33.59% |
ROIC
-232.1%
ROE
-111.5%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -232.05% |
| 2026-03-31 | -281.52% |
| 2025-12-31 | -559.76% |
| 2025-09-30 | -184.08% |
| 2025-06-30 | -137.82% |
| 2025-03-31 | -96.44% |
| 2024-12-31 | -82.75% |
| 2024-09-30 | -83.66% |
| 2024-06-30 | -75.83% |
| 2024-03-31 | -86.67% |
| 2023-12-31 | -82.25% |
| 2023-09-30 | -76.68% |
| 2023-06-30 | -75.89% |
| 2023-03-31 | -97.76% |
| 2022-12-31 | -123.02% |
| 2022-09-30 | -216.04% |
| 2022-06-30 | -210.70% |
| 2022-03-31 | -142.07% |
| 2021-12-31 | -107.28% |
| 2021-09-30 | -67.47% |
| 2021-06-30 | -59.24% |
| 2021-03-31 | -49.76% |
| 2020-12-31 | -48.26% |
| 2020-09-30 | -42.54% |
| 2020-06-30 | -36.39% |
| 2020-03-31 | -34.94% |
| 2019-12-31 | -68.10% |
| 2019-09-30 | -64.04% |
| 2019-06-30 | -53.08% |
| 2019-03-31 | -42.56% |
| 2018-12-31 | -31.73% |
| 2018-09-30 | -69.89% |
| 2018-06-30 | -52.61% |
| 2018-03-31 | -41.44% |
| 2017-12-31 | -36.80% |
| 2017-09-30 | -31.13% |
| 2017-06-30 | -161.76% |
| 2017-03-31 | -115.47% |
| 2016-12-31 | -79.03% |
